Journal of dental hygiene science (치위생과학회지)

The Korean Society of Dental Hygiene Science (한국치위생과학회)
권호 표지
DOI QR코드

DOI QR Code

Oral and Human Microbiome Research

  • Received : 2019.04.26
  • Accepted : 2019.05.21
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

In the past gut microbiome has been the main focus of microbiome research. Studies about the microbiome inside oral cavities and other organs are underway. Studies about the relationship between noninfectious diseases and periodontal diseases, and the negative effects of harmful oral microbes on systemic health have been published in the recent past. A lot of attention is being paid towards fostering a healthy oral microbial ecosystem. This study aimed to understand the roles and effects of the microbiome inside the human body can potentially help cure various diseases including inflammatory bowel diseases with no known cure such as Crohn's disease, atopic dermatitis, obesity, cancer, diabetes, brain diseases and oral diseases. The present study examined technological trends in the correlation between the human microbiome and diseases in the human body, interactions between the human body's immunity, the metabolic system, and the microbiome, and research trends in other countries. While it has been proven that human microbiome is closely correlated with human diseases, most studies are still in the early stage of trying to compare the composition of microbiomes between health and patient groups. Since the oral environment is a dynamic environment that changes due to not only food intake but also other external factors such as lifestyle, hygiene, and drug intake, it is necessary to continue in-depth research on the microbiome composition characteristics to understand the complex functions of oral microorganisms. Analyzing the oral microbiome using computational technology may aid in disease diagnosis and prevention.

Keywords

References

  1. Collins FS, Morgan M, Patrinos A: The Human Genome Project: lessons from large-scale biology. Science 300: 286-290, 2003. https://doi.org/10.1126/science.1084564
  2. Relman DA, Falkow S: The meaning and impact of the human genome sequence for microbiology. Trends Microbiol 9: 206-208, 2001. https://doi.org/10.1016/S0966-842X(01)02041-8
  3. Grice EA, Segre JA: The human microbiome: our second genome. Annu Rev Genomics Hum Genet 13: 151-170, 2012. https://doi.org/10.1146/annurev-genom-090711-163814
  4. Jeffery IB, O'Toole PW: Diet-microbiota interactions and their implications for healthy living. Nutrients 5: 234-252, 2013. https://doi.org/10.3390/nu5010234
  5. Krautkramer KA, Kreznar JH, Romano KA, et al.: Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell 64: 982-992, 2016. https://doi.org/10.1016/j.molcel.2016.10.025
  6. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI: Human nutrition, the gut microbiome and the immune system. Nature 474: 327-336, 2011. https://doi.org/10.1038/nature10213
  7. Lederberg J, McCray AT: 'Ome sweet 'omics - a genealogical treasury of words. Scientist 15: 8, 2001.
  8. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023, 2006. https://doi.org/10.1038/4441022a
  9. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006. https://doi.org/10.1038/nature05414
  10. NIH HMP Working Group, Peterson J, Garges S, et al.: The NIH Human Microbiome Project. Genome Res 19: 2317-2323, 2009. https://doi.org/10.1101/gr.096651.109
  11. Human Microbiome Project Consortium: Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214, 2012. https://doi.org/10.1038/nature11234
  12. Backhed F, Ding H, Wang T, et al.: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101: 15718-15723, 2004. https://doi.org/10.1073/pnas.0407076101
  13. Round JL, Mazmanian SK: The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323, 2009. https://doi.org/10.1038/nri2515
  14. Wold AE: The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 53(46 Suppl): 20-25, 1998. https://doi.org/10.1111/j.1398-9995.1998.tb04953.x
  15. Hanski I, von Hertzen L, Fyhrquist N, et al.: Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A 109: 8334-8339, 2012. https://doi.org/10.1073/pnas.1205624109
  16. Carmody RN, Turnbaugh PJ: Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 124: 4173-4181, 2014. https://doi.org/10.1172/JCI72335
  17. Johnson CH, Patterson AD, Idle JR, Gonzalez FJ: Xenobiotic metabolomics: major impact on the metabolome. Annu Rev Pharmacol Toxicol 52: 37-56, 2012. https://doi.org/10.1146/annurev-pharmtox-010611-134748
  18. Jones ML, Tomaro-Duchesneau C, Prakash S: The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol 22: 306-308, 2014. https://doi.org/10.1016/j.tim.2014.04.010
  19. Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS: Bile acids and the gut microbiome. Curr Opin Gastroenterol 30: 332-338, 2014. https://doi.org/10.1097/MOG.0000000000000057
  20. Sagar NM, Cree IA, Covington JA, Arasaradnam RP: The interplay of the gut microbiome, bile acids, and volatile organic compounds. Gastroenterol Res Pract 2015: 398585, 2015. https://doi.org/10.1155/2015/398585
  21. Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ: The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol 14: 273-287, 2016. https://doi.org/10.1038/nrmicro.2016.17
  22. Pop M, Walker AW, Paulson J, et al.: Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition. Genome Biol 15: R76, 2014. https://doi.org/10.1186/gb-2014-15-6-r76
  23. Arumugam M, Raes J, Pelletier E, et al.: Enterotypes of the human gut microbiome. Nature 473: 174-180, 2011. https://doi.org/10.1038/nature09944
  24. Turnbaugh PJ, Backhed F, Fulton L, Gordon JI: Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3: 213-223, 2008. https://doi.org/10.1016/j.chom.2008.02.015
  25. Turnbaugh PJ, Hamady M, Yatsunenko T, et al.: A core gut microbiome in obese and lean twins. Nature 457: 480-484, 2009. https://doi.org/10.1038/nature07540
  26. Qin J, Li Y, Cai Z, et al.: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60, 2012. https://doi.org/10.1038/nature11450
  27. Udayappan S, Manneras-Holm L, Chaplin-Scott A, et al.: Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes 2: 16009, 2016. https://doi.org/10.1038/npjbiofilms.2016.9
  28. Wlodarska M, Kostic AD, Xavier RJ: An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe 17: 577-591, 2015. https://doi.org/10.1016/j.chom.2015.04.008
  29. Willing BP, Dicksved J, Halfvarson J, et al.: A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139: 1844-1854.e1, 2010. https://doi.org/10.1053/j.gastro.2010.08.049
  30. Gatz M, Pedersen NL: Study of Dementia in Swedish Twins. Twin Res Hum Genet 16: 313-316, 2013. https://doi.org/10.1017/thg.2012.68
  31. Miklossy J: Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 8: 90, 2011. https://doi.org/10.1186/1742-2094-8-90
  32. Shoemark DK, Allen SJ: The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease. J Alzheimers Dis 43: 725-738, 2015. https://doi.org/10.3233/JAD-141170
  33. Koeth RA, Wang Z, Levison BS, et al.: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19: 576-585, 2013. https://doi.org/10.1038/nm.3145
  34. Choi S, Cho SH, Yi H: Human microbiome studies in Korea. Allergy Asthma Respir Dis 4: 311-320, 2016. https://doi.org/10.4168/aard.2016.4.5.311
  35. Sivignon A, Bouckaert J, Bernard J, Gouin SG, Barnich N: The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease. Expert Opin Ther Targets 21: 837-847, 2017. https://doi.org/10.1080/14728222.2017.1363184
  36. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K: Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34: 15490-15496, 2014. https://doi.org/10.1523/JNEUROSCI.3299-14.2014
  37. Arentsen T, Qian Y, Gkotzis S, et al.: The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol Psychiatry 22: 257-266, 2017. https://doi.org/10.1038/mp.2016.182
  38. Kim S, Kim H, Yim YS, et al.: Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature 549: 528-532, 2017. https://doi.org/10.1038/nature23910
  39. Caricilli AM, Saad MJ: The role of gut microbiota on insulin resistance. Nutrients 5: 829-851, 2013. https://doi.org/10.3390/nu5030829
  40. ClinicalTrials.gov: Study of bacteroides thetaiotaomicron in young people aged 16 to 18 years with stable Crohn's disease. Retrieved March 9, 2019, from https://clinicaltrials.gov/ct2/show/NCT02704728(2018, June 28).
  41. ClinicalTrials.gov: A study to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis. Retrieved March 9, 2019, from https://clinicaltrials.gov/ct2/show/NCT02618187(2018, August 27).
  42. Bui TP, Ritari J, Boeren S, de Waard P, Plugge CM, de Vos WM: Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal. Nat Commun 6: 10062, 2015. https://doi.org/10.1038/ncomms10062
  43. Si J, Lee C, Ko G: Oral microbiota: microbial biomarkers of metabolic syndrome independent of host genetic factors. Front Cell Infect Microbiol 7: 516, 2017. https://doi.org/10.3389/fcimb.2017.00516
  44. Dev YP, Khuller N, Basavaraj P, G S: Rheumatoid arthritis among periodontitis patients in Baddi industrial estate of Himachal Pradesh, India: a cross sectional study. J Clin Diagn Res 7: 2334-2337, 2013. https://doi.org/10.7860/JCDR/2013/6237.3518
  45. Khantisopon N, Louthrenoo W, Kasitanon N, et al.: Periodontal disease in Thai patients with rheumatoid arthritis. Int J Rheum Dis 17: 511-518, 2014. https://doi.org/10.1111/1756-185X.12315
  46. Grau AJ, Becher H, Ziegler CM, et al.: Periodontal disease as a risk factor for ischemic stroke. Stroke 35: 496-501, 2004. https://doi.org/10.1161/01.STR.0000110789.20526.9D
  47. Won JH, Ha MN: An association of periodontitis and diabetes. J Dent Hyg Sci 14: 107-113, 2014.
  48. Jung JO: Effects of metabolic syndrome on periodontal diseases in Korean adults. J Dent Hyg Sci 12: 245-252, 2012.
  49. Han GS, Bae KH, Lee MJ, Choi JS: Evaluation of periodontal status according to sociodemographic and health behavior characteristics. J Dent Hyg Sci 8: 395-401, 2008.
  50. Schenkein HA, Loos BG: Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol 40 Suppl 14: S51-S69, 2013. http://doi.org/10.1111/jcpe.12060
  51. Reyes L, Herrera D, Kozarov E, Roldan S, Progulske-Fox A: Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Clin Periodontol 40 Suppl 14: S30-S50, 2013. https://doi.org/10.1111/jcpe.12079
  52. Tonetti MS, Graziani F: The cardiovascular system and oral infections. In: Glick M, ed. The oral-systemic health connection : a guide to patient care. Quintessence Publishing, Hanover Park, pp.139-155, 2014.